Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Abbott selects new motilide as candidate for GI motility disorders

June 26, 1997

Naratriptan highlighted at headache congress; introduced in U.K.

June 26, 1997

Pharmacological profile of TBC-11251, a selective, orally active ETA antagonist

June 25, 1997

SR-49059: a selective vascular V1 receptor antagonist

June 25, 1997

Pharmacokinetics and antihypertensive efficacy of the new AII antagonist CS-866

June 25, 1997

LU-135252 evaluated in models of acute renal failure and hypertension

June 25, 1997

Preclinical and preliminary clinical results reported for alniditan

June 25, 1997

Zolmitriptan: a new antimigraine agent with peripheral and central sites of action

June 25, 1997

Preclinical studies on UR-7280, a potential antihypertensive agent

June 23, 1997

Melatonin reduces the effects of nifedipine in hypertensive patients

June 23, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
PSB-229 reduces plaque burden in Alzheimer’s models
BioWorld Science
Pyroglutamate-modified amyloid-β (pE3-Aβ) is a highly pathogenic Aβ species that accumulates within amyloid plaques and contributes to aggregation,...